Working… Menu

IRinotecan and Oxaliplatin for Colon Cancer in Adjuvant Setting (IROCAS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02967289
Recruitment Status : Recruiting
First Posted : November 18, 2016
Last Update Posted : June 25, 2020
Canadian Cancer Trials Group
Information provided by (Responsible Party):